From: Prognostic factors for progression of osteoarthritis of the hip: a systematic review
Prognostic factor | Studies | Associations | Best-evidence synthesis |
---|---|---|---|
Patient variables | |||
 No association | |||
  Family history of OA | Moderate evidence for no association | ||
 | No, no, no | ||
  Body mass index | Moderate evidence for no association | ||
 | No, no, no, no | ||
 Conflicting evidence | |||
  Higher age at baseline or at first symptoms | Conflicting evidence | ||
 | 1 low risk of bias cohort [32] | Positive No, positive, positive, no | |
  Female | Conflicting evidence | ||
 | 1 low risk of bias cohort [32] | Positive No, no, no, no, positive, no | |
Disease characteristics | |||
 Faster or more progression | |||
  More limitations in physical function at baseline | Moderate evidence for more progression | ||
 | 1 low risk of bias cohort [32] 1 cohort [60] | Positive Positive | |
  Hip pain present at baseline or on most days for a least 1 month in the past year | Moderate evidence for more progression | ||
 | 1 low risk of bias cohort [47] 1 cohort [60] | Positive Positive | |
 No association | |||
  Forestier’s disease | Moderate evidence for no association | ||
 | No, no, no | ||
  Diabetes mellitus | Limited evidence for no association | ||
 | No, no | ||
  Bilateral hip OA | Limited evidence for no association | ||
 | No, no | ||
  Generalized OA | Limited evidence for no association | ||
 | No, no | ||
Chemical or imaging markers | |||
 Faster or more progression | |||
  Subchondral sclerosis | Moderate evidence for more progression | ||
 | 1 low risk of bias cohort [47] 1 cohort [33] | Positive Positive | |
  Neck width of the femoral head | Limited evidence for more progression | ||
 | 1 low risk of bias cohort [21] | Positive | |
  Osteocalcin (OC) | Limited evidence for less progression | ||
 | 1 low risk of bias cohort [63] | Negative | |
 No association | |||
  C-terminal telopeptide of collagen type I (CTX-I) | Strong evidence for no association | ||
 | No, no | ||
  Cartilage oligomeric matrix protein (COMP) | Strong evidence for no association | ||
 | 3 low risk of bias cohorts [44, 53, 63] 1 cohort [26] | No, no, no Positive | |
  N-terminal telopeptide of collagen type I (NTX-I) | Strong evidence for no association | ||
 | No, no | ||
  N-terminal propeptide of procollagen type I (PINP) | Strong evidence for no association | ||
 | No, no | ||
  N-terminal propeptide of procollagen type III (PIIINP) | Strong evidence for no association | ||
 | No, no | ||
  High-sensitive C-reactive protein (hs-CRP) | Moderate evidence for no association | ||
 | 1 low risk of bias cohort [53] 1 cohort [45] | No No | |
  Angle of the femoral head | Moderate evidence for no association | ||
 | 1 low risk of bias cohort [21] | No No, no | |
  Acetabular osteophytes only | Moderate evidence for no association | ||
 | 1 low risk of bias cohort [47] 1 cohort [33] | No No | |
  N-terminal propeptide of procollagen type IIA (PIIANP) | Limited evidence for no association | ||
 | 1 low risk of bias cohort [63] | No | |
  Chondroitin sulphate 846 (CS846) | Limited evidence for no association | ||
 | 1 low risk of bias cohort [63] | No | |
  Cartilage glycoprotein 40 (YKL-40) | Limited evidence for no association | ||
 | 1 low risk of bias cohort [53] | No | |
  Matrix metalloproteinases (MMP-1) | Limited evidence for no association | ||
 | 1 low risk of bias cohort [53] | No | |
  Matrix metalloproteinases (MMP-3) | Limited evidence for no association | ||
 | 1 low risk of bias cohort [53] | No | |
  Neck length of the femoral head | Limited evidence for no association | ||
 | 1 low risk of bias cohort [21] | No | |
 Conflicting evidence | |||
  Bone mineral content | Conflicting evidence | ||
 | 1 low risk of bias cohort [21] | Conflicted$ | |
  Area/size of the hip joint | Conflicting evidence | ||
 | 1 low risk of bias cohort [21] | Conflicted$$ | |
  C-terminal telopeptide of collagen type II (CTX-II) | Conflicting evidence | ||
 | 2 low risk of bias cohorts [53, 63] 1 cohort [59] | Positive, no Positive | |
  Hyaluronic acid (HA) | Conflicting evidence | ||
 | 2 low risk of bias cohorts [53, 63] 1 cohort [23] | Positive, no No | |
  Atrophic bone response (no osteophytes present) | Conflicting evidence | ||
 | 1 low risk of bias cohort [47] | No Positive, positive, no | |
  Subchondral cysts | Conflicting evidence | ||
 | 1 low risk of bias cohort [47] 1 cohort [33] | Positive No | |
  Decrease in joint space width at baseline | Conflicting evidence | ||
 | 1 low risk of bias cohort [32] | Positive No, positive | |
  Superior or (supero) lateral migration of the femoral head | Conflicting evidence | ||
 | Positive, no No, positive | ||
  Higher K-L grade at baseline | Conflicting evidence | ||
 | No, positive, positive, no | ||
  Acetabular index (Horizontal toit externe angle) | Conflicting evidence | ||
 | Conflicted$$$, no | ||
  Wiberg’s center edge angle (CEA) | Conflicting evidence | ||
 | No, negative |